Jing‐Ping Yun

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer.
  2023 L1 71/100

1 assessed by us (0 reproduced) · 79 not yet assessed — every PubMed paper on record, linked below.

• Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma ↗

  Nature · 2026 · PMID 41813900
  not yet assessed
• Retraction: RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma ↗

  Oncotarget · 2026 · PMID 42127300
  not yet assessed
• Exploring the feasibility and educational value of an immersive situational teaching method in a preclinical pathology observation program ↗

  BMC Medical Education · 2026
  not yet assessed
• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma ↗

  JAMA · 2025 · PMID 40079940
  not yet assessed
• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma ↗

  JAMA · 2025 · PMID 40839372
  not yet assessed
• Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after first-line immunochemotherapy ↗

  Radiotherapy and Oncology · 2025 · PMID 40609867
  not yet assessed
• BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma ↗

  Molecular Cancer · 2025 · PMID 40223121
  not yet assessed
• ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma ↗

  Scientific Reports · 2025 · PMID 40210693
  not yet assessed
• Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study ↗

  JHEP Reports · 2025 · PMID 41674893
  not yet assessed
• PD-1 blockade with toripalimab incorporated into induction chemotherapy and radiotherapy with or without concurrent cisplatin in locoregionally advanced nasopharyngeal carcinoma (DIAMOND): A multicenter, non-inferiority, phase 3, randomized controlled trial. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• The prevalence of PD-L1 expression in patients with advanced oesophageal cancer: the EXCEED observational study ↗

  Journal of Clinical Pathology · 2025 · PMID 39875188
  not yet assessed
• Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study ↗

  Frontiers in Immunology · 2025 · PMID 40666526
  not yet assessed
• Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study ↗

  Frontiers in Immunology · 2025 · PMID 41019079
  not yet assessed
• DC-RRG: Diagnosis-centered cascaded radiology report generation ↗

  Expert Systems with Applications · 2025
  not yet assessed
• NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma ↗

  癌症：英文版 · 2023 · PMID 38152992
  not yet assessed
• Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer

  Frontiers in Genetics · 2023 · PMID 37124622
  L1 71/100
• Abstract 2433: SERPINA12 promotes the tumorigenic capacity of hepatocellular carcinoma stem cells through hyperactivation of AKT/β-catenin signaling ↗

  Cancer Research · 2023
  not yet assessed
• Abstract 1755: ADAR1-mediated RNA editing of SCD1 links lipid metabolism to gastric cancer drug resistance and self-renewal ↗

  Cancer Research · 2023
  not yet assessed
• Abstract 2180: The PD-L1 protein expression in Chinese patients with advanced esophageal cancers: a multi-center retrospective study ↗

  Cancer Research · 2023
  not yet assessed
• Abstract 5463: The PD-L1 protein expression in Chinese patients with recurrent or metastatic head and neck squamous cell carcinoma: A multi-center retrospective study ↗

  Cancer Research · 2023
  not yet assessed
• Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients ↗

  Frontiers in Immunology · 2022 · PMID 36591236
  not yet assessed
• H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum ↗

  Theranostics · 2022 · PMID 35832076
  not yet assessed
• Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicine ↗

  Research Square · 2022
  not yet assessed
• The association of HHLA2 and PD-L1 expression with prognosis and immune microenvironment in hepatocellular carcinoma ↗

  Research Square · 2022
  not yet assessed
• Corrigendum to “DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer” [Canc. Lett. (2022 Apr 28) 532 215585] ↗

  Cancer Letters · 2022 · PMID 35477591
  not yet assessed
• Unsupervised content-preserving transformation for optical microscopy ↗

  Light Science & Applications · 2021 · PMID 33649308
  not yet assessed
• Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses ↗

  Molecular Cancer · 2021 · PMID 33430876
  not yet assessed
• A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer ↗

  EBioMedicine · 2021 · PMID 34280779
  not yet assessed
• Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis ↗

  Cancer Letters · 2021 · PMID 34767927
  not yet assessed
• Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma ↗

  Frontiers in Cell and Developmental Biology · 2021 · PMID 33748106
  not yet assessed
• The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers ↗

  Experimental Hematology and Oncology · 2021 · PMID 33397433
  not yet assessed
• Time-varying effects of FOXA1 on breast cancer prognosis ↗

  Breast Cancer Research and Treatment · 2021 · PMID 33604715
  not yet assessed
• PD-L1 Expression in Chinese Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Multi-Center Retrospective Observational Study ↗

  Journal of Cancer · 2021 · PMID 35003359
  not yet assessed
• Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients ↗

  OncoImmunology · 2021 · PMID 34721946
  not yet assessed
• Association of preoperative and postoperative CA72‐4 with gastric cancer outcome ↗

  Journal of Surgical Oncology · 2021 · PMID 33684249
  not yet assessed
• Clinicopathological and Prognostic Characteristics of Esophageal Spindle Cell Squamous Cell Carcinoma: An Analysis of 43 Patients in a Single Center ↗

  Frontiers in Oncology · 2021 · PMID 33777730
  not yet assessed
• Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 ↗

  Molecular Cancer · 2021
  not yet assessed
• Correction to: KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity ↗

  Journal of Experimental & Clinical Cancer Research · 2021 · PMID 33863368
  not yet assessed
• Additional file 2 of Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses ↗

  Open MIND · 2021
  not yet assessed
• H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts ↗

  Theranostics · 2020 · PMID 33391546
  not yet assessed
• Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology ↗

  Journal for ImmunoTherapy of Cancer · 2020 · PMID 32690665
  not yet assessed
• A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma ↗

  JNCI Journal of the National Cancer Institute · 2020 · PMID 33094348
  not yet assessed
• Intake of Alcohol and Tea and Risk of Nasopharyngeal Carcinoma: A Population-Based Case–Control Study in Southern China ↗

  Cancer Epidemiology Biomarkers & Prevention · 2020 · PMID 33303643
  not yet assessed
• Correction: <i>Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study</i> ↗

  Journal for ImmunoTherapy of Cancer · 2020 · PMID 32690666
  not yet assessed
• Additional file 1 of CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 ↗

  Open MIND · 2020
  not yet assessed
• Additional file 5 of CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 ↗

  Figshare · 2020
  not yet assessed
• N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis ↗

  Nature Communications · 2019 · PMID 31619685
  not yet assessed
• Prospective observation: Clinical utility of plasma Epstein–Barr virus DNA load in EBV‐associated gastric carcinoma patients ↗

  International Journal of Cancer · 2019 · PMID 31162842
  not yet assessed
• Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis ↗

  Journal for ImmunoTherapy of Cancer · 2019 · PMID 31722750
  not yet assessed
• Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population‐based case‐control study ↗

  Cancer · 2019 · PMID 31544233
  not yet assessed
• Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population‐based case–control study in Southern China ↗

  Cancer Medicine · 2019 · PMID 30793524
  not yet assessed
• Correction to: KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity ↗

  Journal of Experimental & Clinical Cancer Research · 2019 · PMID 31666105
  not yet assessed
• Association of Kras mutation with tumor deposit status and overall survival of colorectal cancer ↗

  medRxiv · 2019
  not yet assessed
• Prognostic significance of tumor‐infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large‐scale cohort study ↗

  International Journal of Cancer · 2018 · PMID 29377121
  not yet assessed
• A Coiled‐Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine‐Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway ↗

  Hepatology · 2018 · PMID 30028541
  not yet assessed
• A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection ↗

  Cancer Management and Research · 2018 · PMID 30288102
  not yet assessed
• Reproductive history and risk of nasopharyngeal carcinoma: A population-based case–control study in southern China ↗

  Oral Oncology · 2018 · PMID 30616779
  not yet assessed
• Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study ↗

  Journal of Thoracic Disease · 2018 · PMID 30416772
  not yet assessed
• [Interpretation of the fourth edition of WHO pathological classification of the thyroid tumors in 2017]. ↗

  PubMed · 2018 · PMID 30293272
  not yet assessed
• <i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis ↗

  Molecular Oncology · 2017 · PMID 28580773
  not yet assessed
• Radiotherapy for Patients With Resected Tumor Deposit–Positive Colorectal Cancer: A Surveillance, Epidemiology, and End Results–Based Population Study ↗

  Archives of Pathology & Laboratory Medicine · 2017 · PMID 29048218
  not yet assessed
• Erratum to: CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling ↗

  Journal of Experimental & Clinical Cancer Research · 2017
  not yet assessed
• MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4 ↗

  Oncotarget · 2015 · PMID 26204489
  not yet assessed
• Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma ↗

  Oncotarget · 2015 · PMID 26317793
  not yet assessed
• Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma ↗

  Oncotarget · 2015 · PMID 25965822
  not yet assessed
• Facts about Endosalpingiosis ↗

  Open Journal of Obstetrics and Gynecology · 2015
  not yet assessed
• Increased Expression of CAP2 Indicates Poor Prognosis in

  2015
  not yet assessed
• Friend Leukemia Virus Integration 1 Expression Has Prognostic Significance in Nasopharyngeal Carcinoma ↗

  Translational Oncology · 2014 · PMID 25171891
  not yet assessed
• Low cyclin <scp>F</scp> expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis ↗

  Cancer Science · 2013 · PMID 23305207
  not yet assessed
• MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma ↗

  PLoS ONE · 2013 · PMID 23717574
  not yet assessed
• Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma ↗

  PLoS ONE · 2012 · PMID 23272146
  not yet assessed
• Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis ↗

  PLoS ONE · 2012 · PMID 22829937
  not yet assessed
• The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability ↗

  癌症：英文版 · 2012 · PMID 22704487
  not yet assessed
• Increased expression of ZBP‐89 and its prognostic significance in hepatocellular carcinoma ↗

  Histopathology · 2012 · PMID 22372401
  not yet assessed
• Identification of a gene‐expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma ↗

  Cancer · 2011 · PMID 21319141
  not yet assessed
• Adenovirus‐mediated tBid overexpression results in therapeutic effects on p53‐resistant hepatocellular carcinoma ↗

  International Journal of Cancer · 2006 · PMID 16708390
  not yet assessed
• Overexpression of NPM/B23 correlates with malignancies of hepatocellular carcinoma

  Cancer Research · 2006
  not yet assessed
• Nuclear matrix protein expressions in hepatocytes of normal and cirrhotic rat livers under normal and regenerating conditions ↗

  Journal of Cellular Biochemistry · 2004 · PMID 15048880
  not yet assessed
• Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix ↗

  Journal of Cellular Biochemistry · 2003 · PMID 14635188
  not yet assessed
• Morphological and quantitative study on stromal microvasculature of nasopharyngeal precancerous lesions ↗

  Chinese Journal of Cancer Research · 1996
  not yet assessed